Insight

Recent Articles

The trouble with tech M&A

May 15, 2012 : M&A

U.S. M&A volume may be at the lowest level since early 2003, but  technology deals are on a tear more »

Can Pharma Turn the Oceanliner Around?

May 14, 2012 : Big Pharma

In introducing biotech guru G. Steven Burrill today, Illinois BIO (iBIO) president David Miller likened the speaker to the Michael Jordan of biotechnology. “There will never be the next Steven Burrill,” he said. “At a critical time in biotech’s development, he was there.” more »

Dealmakers weekly review – May 7 2012 – Royalty Pharma, Fumapharm, Pfizer, Quark, Novartis, Fougera, Hologic, Gen-Probe

May 8, 2012 : dealtalk

Partnering buoyant with numerous bigpharma deals annnounced in the past week. M&A also saw several billion dollar deals more »

CurrentAgreements Deals Update: May 2012

May 8, 2012 : dealtalk

This month we are providing you with an overview of deal making activity in the life sciences, covering partnering and M&A in April 2012 more »

Can portfolio theory save lives?

May 8, 2012 : dealtalk

With U.S. biomedical research under assault by everyone from patients to Congress for turning so few scientific discoveries into treatments, a leading finance expert says decisions about what studies to bankroll should be made the same way pension funds, mutual funds, and university endowments decide how to invest their money more »

more

Points of view

Hologic buys Gen-Probe for $3.7 billion

May 1, 2012

In a joint statement, Hologic announced it is to acquire Gen-Probe, in a deal valued at $37 billion more »

Jazz makes another acquisition, this time Eusa

April 30, 2012

A mere few months after acquiring Azur Pharma, Jazz is at it again, this time acquiring Eusa Pharma for $700 million more »

AstraZeneca acquires Ardea for $1.26 billion; gains Lesinurad

April 25, 2012

In a deal valued at $1.26 billion, AstraZeneca has snapped up Ardea Biosciences, gaining access to Ardea’s lead drug for the treatment of gout, Lesinurad, in the process more »

View all points of view articles

Glossary

Royalty financing

April 26, 2012

Top 50 Pharma

July 1, 2011

Two-step merger

April 5, 2011

Second-step merger

April 5, 2011

Warranties

April 3, 2011

View all glossary entries